from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1826/gcvH

LFCtreatmentdescriptionclass of inhibitor

0.565

Amikacinug/mL Amikacintranslation

0.819

Cap5-10ug/mL Capreomycintranslation

0.758

Rox10-50 ug/mL Roxithromycintranslation

0.447

SM2-5 ug/mL Streptomycintranslation

0.229

Tet5-10 ug/mL Tetracyclinetranslation

-0.448

Rif0.2-5ug/mL Rifampicintranscription

-0.391

Rifp0.1-0.5ug/mL Rifapentinetranscription

1.426

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-2.400

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.281

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.712

Clofazimine10-13 ug/mL Clofaziminerespiration

0.099

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-3.088

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-2.994

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.394

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.100

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.571

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.804

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.943

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-1.017

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-2.257

KCN5-20 ug/mL Potassium cyaniderespiration

-0.877

NaN30.2-2 mM Sodium aziderespiration

1.064

Nigericin50 uM Nigericinrespiration

-1.264

TRC10-150 ug/mL Triclosanrespiration

-1.241

TRZ10-25 ug/mL Thioridazinerespiration

-0.089

Valinomycin0.5-10 uM Valinomycinrespiration

0.415

ZnSO42 mM ZnSO4respiration

-0.641

menadione6-10 ug/mL Menadionerespiration

0.378

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.607

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.217

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.506

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

1.151

NRP_1Non-replicating persistence stage 1dosRassociated

0.689

Amp0.2mg/mL AmpicillincellWall

0.441

Cephalexin20-100 ug/mL CephalexincellWall

0.541

Cerulenin0.32-5 ug/mL CerulenincellWall

0.323

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.403

EMB10-20 ug/mL EthambutolcellWall

0.373

Eta12-40 ug/mL EthionamidecellWall

0.657

INH0.2-0.4 ug/mL IsoniazidcellWall

0.199

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.474

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.439

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.058

BZA0.12 mg/mL BenzamidearomaticAmides

0.235

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.024

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.284

H2O24 mM hydrogen peroxideDNAdamaging

-0.056

Levo10 ug/mL LevofloxacinDNAdamaging

0.781

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-2.429

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.349

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.649

UVUV-irradiationDNAdamaging

-0.168

ARP41-4 ug/mL Antitubercular compound ARP4?

0.488

Antimycin12.5-50 ug/mL Antimycin A?

0.433

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.222

PA_110-50 ug/mL Antitubercular compound PA-1?

0.313

PA_2110-50 ug/mL Antitubercular compound PA-21?

-1.207

PA8240.2-2 ug/mL PA-824?

-0.797

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.208

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.634

Verapamil50 uM Verapamil?

0.636

mercaptoethanol2 mM 2-Mercaptoethanol?

0.437

methoxatin10-20 ug/mL Methoxatin?